Weight Loss Drug User Reports Stalled Progress, Appetite Surge After Alcohol Consumption
Seoul, South Korea – A South Korean journalist documenting his experience with the weight loss drug Maunjaro (tirzepatide) reported a plateau in weight loss and a resurgence of appetite after consuming a single glass of beer, highlighting the challenges of adhering to lifestyle modifications while on medication. Jeong Dong-hoon,a reporter for Asiae,began publicly tracking his progress with Maunjaro and shared detailed body composition data.
The report underscores the significant individual variation in response to weight loss treatments, even with consistent dosage and dietary efforts. While initially experiencing positive changes in body weight and fat mass, Jeong’s progress stalled during weeks four through six, coinciding with the Korean holiday Chuseok and a business trip. Weight fluctuated between 90 and 91 kg, and fat mass showed inconsistent decreases and increases. notably, increasing the Maunjaro dosage from 2.5mg to 5mg did not result in a proportional increase in weight loss.
Jeong observed that even minor deviations from strict adherence to diet and lifestyle – as exemplified by the single beer – triggered a noticeable increase in appetite. The accompanying body composition data,collected under consistent conditions (morning,fasting,before showering),demonstrates the importance of focusing on overall trends rather than daily fluctuations,which can be affected by hydration levels and food intake. The journalist’s ongoing documentation aims to provide real-world insight into the complexities of pharmaceutical weight loss and the critical role of sustained behavioral changes.
